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Abstract
Background: Recurrence and severity of Crohn's disease mucosal lesions after "curative" ileal resection is assessed at 
endoscopy. Intramural lesions can be detected as increased wall thickness at Small Intestine Contrast Ultrasonography 
(SICUS).
Aims. To assess after ileal resection whether: 1) SICUS detects recurrence of Crohn's disease lesions, 2) the intestinal wall 
thickness measured at the level of ileo-colonic anastomosis predicts the severity of endoscopic lesions, 3) the 
extension of intramural lesions of the neo-terminal ileum is useful for grading severity of the recurrence, 4) the 
combined measures of wall thickness of the ileo-colonic anastomosis and of the extension of intramural lesions at level 
of the neo-terminal ileum may predict the endoscopic Rutgeerts score
Methods: Fifty eight Crohn's disease patients (M 37, age range 19-75 yrs) were prospectively submitted at 6-12 months 
intervals after surgery to endoscopy and SICUS for a total of 111 observations.
Results: Six months or more after surgery wall thickness of ileo-colonic anastomosis > 3.5 mm identified 100% of 
patients with endoscopic lesions (p < 0.0001). ROC curve analysis, combining wall thickness of ileo-colonic 
anastomosis and the extension of intramural lesions of neo-terminal ileum, discriminated (0.95) patients with, from 
those without, endoscopic lesions. Performing two multiple logistic regression analyses only wall thickness of ileo-
colonic anastomosis and extension of neo-terminal ileum intramural lesions were significantly associated with absence 
or presence of endoscopic lesions. An ordinal polychotomus logistic model, considering all investigated variables, 
confirmed that only SICUS variables were associated with endoscopic grading of severity.
Conclusions: In patients submitted to ileal resection for Crohn's disease non-invasive Small Intestine Contrast 
Ultrasonography 1) by assessing thickness of ileo-colonic anastomosis accurately detects initial, minimal Crohn's 
disease recurrence, and 2) by assessing both thickness of ileo-colonic anastomosis and extension of intramural lesions 
of neo-terminal ileum grades the severity of the post-surgical recurrence.
Background
In patients submitted to surgery for ileo-colonic Crohn's
disease (CD), recurrence of CD intestinal lesions at the
level of ileo-colonic anastomosis and neo-terminal ileum
is extremely common. Indeed, it is now firmly established
that surgery, even though apparently radical and despite
initial clinical remission, does not offer a definitive cure.
So far the natural course of initial, minimal postoperative
lesions at the level of neo-terminal ileum has been
assessed with ileo-colonoscopy and a seminal prospective
endoscopic cohort study demonstrated that the severity
of postoperative recurrent CD lesions is the best predic-
tor of the clinical outcome [1]. Endoscopy, however, is an
invasive procedure that reduces the patient's compliance
to regular follow-up controls preventing the detection of
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early and low grade recurrent lesions [2,3]. Furthermore,
the intramural nature of Crohn's disease intestinal lesions
cannot be assessed with endoscopy. Small intestine con-
trast ultrasonography (SICUS) performed after the inges-
tion of oral contrast makes possible to measure the wall
thickness and the luminal diameter of the small bowel
[4,5]. In Crohn's disease of the small bowel intramural
lesions cause an increased thickness of the intestinal wall
that can be accurately detected with the non invasive
SICUS [6,7]. In patients submitted to ileal resection, pre-
vious oral contrast ultrasound studies [8,9], assessing the
wall thickness of the neo-terminal ileum, showed a low
sensitivity in detecting initial, low grade CD recurrence
(i.e. Rutgeerts score 1 and 2) that may be limited only to
the ileo-colonic anastomosis [1]. Therefore the aims of
the present study were to assess in CD patients submitted
to ileal resection whether
1. a non invasive technique such as SICUS can be 
used to detect minimal CD lesions, i.e. low grade 
recurrence limited to ileo-colonic anastomosis
2. the intestinal wall thickness measured at the level of 
ileo-colonic anastomosis can predict the severity of 
endoscopic lesions according to Rutgeerts score
3. the evaluation of the extension of intramural 
lesions at the level of the neo-terminal ileum may be 
useful for grading the severity of the recurrence
4. the combined measures of wall thickness of the 
ileo-colonic anastomosis and the extension of wall 
thickening of the neo-terminal ileum may predict the 
endoscopic Rutgeerts score
Methods
Patients
As a part of a long-term prospective follow up study 58
consecutive patients with Crohn's disease of the small
bowel, submitted to resection of macroscopically dis-
eased bowel, were evaluated since the year 2000. Patients
underwent surgery because of the following conditions;
32 (55%) for symptomatic obstructive ileal strictures, 8
(14%) for abscess and fistulae, 2 (3%) for perforation, 15
(26%) for strictures and fistulae/abscess and 1 unrespon-
sive to medical treatment.
Medical history, including abdominal and extra-
abdominal complaints, associated disease, CD behaviour,
smoking status at diagnosis, CDAI at referral, family his-
tory, location of CD, duration of the disease before sur-
gery, number of surgical resections, post-operative
medical treatment and pathological studies of the resec-
tion specimen and of the section margins were assessed.
Informed consent was obtained from each subject and
the study protocol was approved by the local ethics com-
mittee of our University Hospital # 918.
Protocol of the study
Patients were prospectively evaluated with SICUS and
ileo-colonoscopy with scheduled follow-up at 6 months
and 1 year after surgery and at regular intervals of 6-12
months thereafter. Each patient was initially submitted to
a standardized clinical interview and a physical examina-
tion performed by certified and experienced gastroenter-
ologists. Patients were then consecutively submitted to
biochemistry, SICUS and within 2 weeks interval on dif-
ferent days and in random order, to a ileo-colonoscopy.
When deemed necessary additional investigations,
including upper GI endoscopy, abdominal CT or MRI
were performed. SICUS examinations and ileo-colonos-
copy were performed by experienced gastroenterologists
aware of the diagnosis and clinical data, including bowel
surgery, but each blinded to the results of other investiga-
tions and previous SICUS examinations.
Small intestine contrast ultrasonography (SICUS)
Real-time ultrasound (US) was performed using Toshiba
Tosbee (Tokyo, Japan) equipment with a 3.5 MHz convex
and a 5 MHz linear array transducers. The apparatus can
detect a bowel wall thickness (BWT) variation of 0.1 mm.
Sonologist (NP) has performed more than 9,000 SICUS
examinations.
SICUS was performed after an overnight fasting
according to a previously published [4] method. Briefly,
after the ingestion of 375 ml of macrogol contrast oral
solution and after the contrast was seen to flow through
the neo-terminal ileum into the colon, a retrograde fol-
low-through assessment of the entire small bowel was
performed visualizing, in a caudo-cranial sequence, the
contrast-filled ileal and jejunal loops. The body position
of patients was changed and abdominal compression with
the ultrasound (US) transducer was used, whenever
required, to improve visualization of any single loop and
detection of intestinal abnormalities after the ingestion of
the oral contrast. Wall thickness and lumen diameter
were measured at several sites (proximal, middle and dis-
tal) of the small bowel at the level of maximally distended,
and not contracting, intestinal loops. Wall thickness of
the ileo-colonic anastomosis (ICA) including the ileal and
colonic limbs (figure 1A) was calculated as the average of
at least 3 measurements. Each ileal and colonic limb were
separately measured from the mucosa to the outer rim of
the muscularis propria. Maximal lumen diameter at the
passage of the oral contrast at the level of ileo-colonic
anastomosis was measured.
US criteria for recurrence of CD in the neo-terminal
ileum was increased wall thickness (> 3 mm). The exten-
sion of the increased intestinal wall thickness (> 3 mm)
(figure 1B) was reported as the average of at least 3 mea-
surements.
Bowel stenosis was defined as lumen diameter less than
1 cm [5] measured at the level of neo-terminal ileum and/
or ileo-colonic anastomosis. Bowel dilatation, defined as
lumen diameter >2.5 cm [6,7], was also looked for.
At the end of the US investigation measurements of
intestinal wall and lumen alterations at the level of ileo-Pallotta et al. BMC Gastroenterology 2010, 10:69
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colonic anastomosis and small bowel were reported on a
standardized form.
Ileocolonoscopy
Ileo-colonoscopy was performed by experienced gastro-
enterologists (MG, AG, FB, MT, AC) with experience of
more than 15,000 examinations. Unless hampered by
luminal stricture, the neo-terminal ileum was examined
for 30 cm above the anastomosis. Multiple mucosal biop-
sies of neo-terminal ileum and the anastomotic large
bowel were obtained in endoscopically normal mucosa as
well as in the reddened mucosa in the proximity of epi-
thelial lesions. The anastomosis was carefully inspected.
At the end of the endoscopy, presence of mucosal lesions
and grading according to Rutgeerts score [1] were
reported on a standardized form. Ileal lesions were
scored at ileocolonscopy as follows: 0, no lesions; 1, ≤5
aphtous lesions; 2, > 5 aphtous lesions with normal
mucosa between the lesions or skip areas of larger lesions
or lesions confined to the ileo-colonic anastomosis (i.e. <
1 cm in length); 3, diffuse aphtous ileitis with diffusely
inflamed mucosa; 4, diffuse inflammation with already
larger ulcers, nodules, and/or narrowing. Extension of
mucosal lesions was also reported.
Statistical analysis
In the analysis only pairs of SICUS and ileo-colonoscopy
performed 2 weeks apart were included. To provide a
descriptive comparison of patients and of US values, i.e.
wall thickness at the level of ileo-colonic anastomosis and
intramural lesions (wall thickness > 3 mm) at the level of
neo-terminal ileum, arithmetic mean, standard deviation,
median values and interquartile ranges were calculated.
Box-plots [10] were used to provide an immediate graph-
ical evaluation of US values by Rutgeerts score.
To our knowledge the normal wall thickness of the ICA
has never been reported. Based on preliminary analysis
an ICA wall thickness equal or more than 3.5 mm showed
to better discriminate patients without, from those with,
endoscopic lesion (score 1-4). Thereafter ICA wall thick-
ness was dichotomised in the two categories ≤ 3.5 mm
and > 3.5 mm, and endoscopic score in the two categories
0 and 1-4. Spearman correlation test was used to assess
the relation between wall thickness values at the level of
ileo-colonic anastomosis and extension of neo-terminal
intramural lesions as measured by SICUS.
Univariate ordinal logistic regression models were
applied to evaluate whether there was an association of
SICUS values, age, gender, presence of symptoms, CDAI
(< 150 or ≥150), CD duration before surgery, time interval
between surgery and SICUS evaluation, with the different
endoscopic scores. In order to assess the association of
several characteristics in patients with less severe scores,
patients with score ≥2 were grouped together. We further
performed two multiple logistic regression analyses with
outcomes score 0 vs > 0, and score 0 vs 1 (i.e., restricted
only to Rutgeerts endoscopic score < 2), obtained
through a backward selection strategy having excluded
factors with a p-value > 0.20 obtained by a likelihood-
ratio test. From these two logistic models, receiver oper-
ating characteristic (ROC) curves were then constructed
to quantify the accuracy of combined measures of wall
Figure 1 A. SICUS assessment of ileo-colonic anastomosis. Calipers indicate thickness of ileal (up) (1.9 mm) and colonic (down) (1.2 mm) limbs. 
Arrowhead indicates colon, arrow indicates neo-terminal ileum. B. SICUS assessment of ileo-colonic anastomosis and neo-terminal ileum. CD 
intramural involvement of ileo-colonic anastomosis (thickness 10 mm see arrows) and neo-terminal ileum (extending for 8 cm, see arrowhead).Pallotta et al. BMC Gastroenterology 2010, 10:69
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thickness of ileo-colonic anastomosis and extension of
neo-terminal intramural lesions in discriminating score 0
from score 1-4, and score 0 from score 1. Finally, an ordi-
nal logistic regression model was fitted including as cova-
riates wall thickness of ileo-colonic anastomosis and
extension of neo-terminal intramural lesions. The results
from this model were then used to provide prediction of
the risk of being classified in each of the three categorical
endoscopic score (0, 1, and ≥2) for any given combination
values of these two variables.
All the standard errors of the estimated parameters
obtained by the previously described analyses were
adjusted to take into account that the repeated measure-
ments at different times for the same patient were clus-
tered within the patient [11]. Two-sided p-values were
defined statistically significant when P < 0.05, and mar-
ginally significant when 0.05 <P < 0.2. All the analyses
were performed using STATA release 8.0 [12].
Results
A complete SICUS investigation was performed in all
evaluated patients after the ingestion of 375 mL of mac-
rogol solution and none experienced any adverse event.
According to the study protocol the first observation
was performed at 6 months after surgery in 19 patients
(33%), at 12 months in 16 (28%), at 18 months in 5 (9%),
and at 24 months in 18 patients (31%). Since not all
patients underwent colonoscopy at the scheduled time,
18/58 patients performed one SICUS-ileocolonoscopy
paired evaluation during a follow-up period of 35 ± 33
months (range 6-100), 25/58 two evaluations during a fol-
low-up period of 44.6 ± 24.3 months (range 12-99), 13/58
three evaluations during a follow-up period of 59 ± 20.5
months (range 32-94) and 1 patient four evaluations dur-
ing a follow-up period of 56 months for a total of 111
paired evaluations.
At 6 months after surgery, 58% of evaluated patients did
not have recurrence (i.e. score 0), 31% had score 1 and
11% score ≥2. At 12 months after surgery 38% of evalu-
ated patients did not have recurrence (i.e. score 0), 38%
had score 1 and 24% score ≥2. At 24 months after surgery
6% of evaluated patients did not have recurrence (i.e.
score 0), 22% had score 1 and 72% score ≥2.
US and endoscopic findings
The main demographic and clinical characteristics and
ileocolonoscopy of study population are reported in table
1. The total of 111 paired SICUS and ileo-colonoscopy
observations performed 2 weeks apart were included in
the analysis.
Endoscopic score was 0 in 29 observations, 1 in 31, 2 in
18, 3 in 10 and 4 in 23. At SICUS, wall thickness of ileo-
colonic anastomosis was 3 mm (median, IQR 2.5-3.8
mm) in patients with endoscopic score 0. It was 7 mm
(median, IQR 6-9 mm) in patients with score 1. It was 9.8
mm (median, IQR 8-12 mm) in patients with score 2. It
was 11 mm (median, IQR 9-13 mm) in patients with
score 3, and 10 mm (median, IQR 9-12 mm) in those with
Table 1: Main demographic, endoscopic at first assessment 
and clinical characteristics of investigated subjects 
according to Montreal classification
Gender (M/F) 37/21
Median age (range years) 45.4 yrs (19-75 yrs)
Duration of Crohn's disease before surgery 44 ± 55 months
Illness behaviour at diagnosis (%)
B1 4 (7%)
B2 32 (55%)
B3 22 (38%)
Location (%)
L1 28 (48%)
L3 26 (45%)
L3+L4 4 (7%)
Previous surgical resection (%)
2 11 (19%)
32  ( 3 % )
Type of anastomosis
Side to side 42 (72%)
End to side 11 (19%)
End to end 5 (9%)
Pathological findings at resection margins
Negative 35 (60%)
Positive 6 (11%)
Not-reported 17 (29%)
Post-operative treatment
5-ASA 44 (75%)
Azathioprine 14 (25%)
Rutgeerts score at first assessment (%)
Score 0 20 (34%)
Score 1 15 (26%)
Score 2 7 (12%)
Score 3 5 (9%)
Score 4 11 (19%)Pallotta et al. BMC Gastroenterology 2010, 10:69
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score 4. There was a significant association between score
0/score 1-4 and wall thickness at the level of ileo-colonic
anastomosis less or equal to 3.5 mm compared to more
than 3.5 mm (p < 0.001). At the level of ileo-colonic anas-
tomosis a wall thickness of more than 3.5 mm identified
100% of the patients with endoscopic score of 1-4 (figure
2A).
Wall thickness of ileo-colonic anastomosis was signifi-
cantly greater in patients with Rutgeerts score 4, 3 and 2
compared to 1 (p < 0.001 for all comparisons) and in
patients with score 1 compared to 0 (p < 0.001). Wall
thickness of ileo-colonic anastomosis did not significantly
differ among patients with score 2, 3 and 4 (figure 2A).
At SICUS the extension of intramural lesions (wall
thickness > 3 mm) in the neo-terminal ileum was 1 cm
(median, IQR 1-6.5 cm), 10 cm (median, IQR 2-20 cm),
10 cm (median, IQR 5-13 cm), and 16 cm (median, IQR
9-25 cm) in patients with score 1, 2, 3 and 4, respectively
(figure 2B). The extension of intramural lesions at the
level of neo-terminal ileum was significantly greater in
patients with Rutgeerts score 4 (p < 0.001), 3 (p = 0.03)
and 2 (p = 0.04) compared to score 1 and did not signifi-
cantly differ among patients with score 2, 3 and 4 (figure
2B).
In 6 patients with early recurrence at 6 months after
surgery endoscopic severity score was 1 and at SICUS
wall thickness of the ileo-colonic anastomosis was 5-10
mm. In 4 patients with score 0 at ileocolonoscopy,
Crohn's disease recurrent lesions, confirmed by MRI,
were detected at SICUS as wall thickness of ileo-colonic
anastomosis ranging between 5 mm and 12 mm (figure
2A) and as ileal-side extension of intramural lesion rang-
ing between 3 cm and 8 cm (figure 2B). Histological
inflammation was present in the biopsy of ileo-colonic
anastomosis and neo-terminal ileum in all 4 patients.
In patients with score 1, CD lesions were confined at
ileo-colonic anastomosis in 29/31 (93%) patients at
endoscopy and in 17/31 (54%) patients at SICUS. In 18/23
(78%) patients with score 4 the presence of stricture of
ileo-colonic anastomosis did not enable to assess at
endoscopy the pre-anastomotic ileal mucosa. In the
remaining 5 patients the extension of mucosal lesion at
endoscopy was significantly less than the extension of
intramural lesion at SICUS (11 ± 3 cm vs 23 ± 16 cm). At
SICUS a stenosis was confined at ileo-colonic anastomo-
sis in 8 patients, its length was > 5 cm in 9 patients, and 3
cm in 1. There was a fair correlation (r = 0.467, p < 0.001)
between wall thickness at the level of the ileo-colonic
Figure 2 A. Box-and-whiskers plots of wall thickness at the level of ileo-colonic anastomosis according to different Rutgeerts score. The 
boxes at each score extend from the 25th percentile (x[25]) to the 75th percentile (x[75]) [i.e., the interquartile range (IQ)]; the lines inside the boxes rep-
resent the median values. The line emerging from the boxes (i.e., the "whiskers") extend to the upper and lower adjacent values. The upper adjacent 
value is defined as the largest data point ≤x[75] + 1.5 × IQ, and the lower adjacent value is defined as the smallest data point ≥x[25] - 1.5 × IQ. Observed 
values more extreme than the adjacent values, if any, are individually plotted (circles). * p < 0.001 score 1 vs score 0, 2-4. The horizontal line indicates 
the cut-off value of 3.5 mm. B. Box-and-whiskers plots of extension of intramural lesion at the level of neo-terminal ileum according different 
Rutgeerts score. The boxes at each time unit extend from the 25th percentile (x[25]) to the 75th percentile (x[75]) [i.e., the interquartile range (IQ)]; the 
lines inside the boxes represent the median values. The line emerging from the boxes (i.e., the "whiskers") extend to the upper and lower adjacent 
values. The upper adjacent value is defined as the largest data point ≤x[75] + 1.5 × IQ, and the lower adjacent value is defined as the smallest data point 
≥x[25] - 1.5 × IQ. Observed values more extreme than the adjacent values, if any, are individually plotted (circles). * p < 0.001 score 1 vs score 4, ** p = 
0.03 score 1 vs score 2, *** p = 0.04 score 1 vs score 3Pallotta et al. BMC Gastroenterology 2010, 10:69
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anastomosis and extension of neo-terminal intramural
lesions as assessed at SICUS (figure 3).
Association of demographic, clinical and US values with 
Rutgeerts severity score
Table 2 shows the association between demographic,
clinical and US characteristics by the Rutgeerts severity
score (i.e., 0, 1, and ≥2). At univariate analysis, the wall
thickness value at the level of ileo-colonic anastomosis
(ICA), the extension of intramural lesions at the level of
neo-terminal ileum, age, and post-operative CD activity
index (CDAI) at referral, were all significantly associated
with Rutgeerts severity score. The older age and CDAI
≥150, while neither the disease duration before surgery,
nor symptoms at referral, were associated with high
grade severity of Rutgeerts score. Performing two multi-
ple logistic regressions with outcome 0 vs > 1 - 4 and 0 vs
1, after a backward selection, only ileo-colonic wall thick-
ness and extension of neo-terminal ileum intramural
lesions were significantly associated with Rutgeerts score
(Table 3).
It is of note that after adjusting for US variables, no sta-
tistically significant relationship was found with age and
CDAI ≥150 when ICA wall thickness and extension of
neo-terminal intramural lesions were entered in these
models.
The ROC curve analysis combining the wall thickness
of the ileo-colonic anastomosis with the extension of neo-
terminal ileum intramural lesions shows a value of 0.95
(i.e., very good, given that 1 means perfect discrimina-
tion) in discriminating patients with score 0 from 1-4 and
a value of 0.90 (i.e. good) in discriminating patients with
score 0 from 1 (figure 4A and 4B).
The ordinal polychotomous logistic model analysis
obtained after a backward selection starting from all vari-
ables investigated (see Table 2), in which the outcome was
the Rutgeerts score severity (i.e., 0, 1, ≥2), showed again
that only the US variables were associated with score
severity (ICA wall thickness, for 1 mm increase: coeffi-
cient 0.73, 95%, CI 0.41-1.05, p < 0.001; extension of
increased neo-terminal ileal wall thickness, for 1 cm
increase: coefficient 0.14, 95% CI 0.08-0.21, p < 0.001).
After adjusting for US variables the duration of disease
before surgery was marginally associated with Rutgeerts
score severity (coefficient 0.01, 95% CI 0.001-0.021 per
one month increase, p = 0.07) (data not included in the
table). Estimated risks of having/not having CD recur-
rence after surgery, taking into account both wall thick-
ness at the level of ileo-colonic anastomosis and
extension of neo-terminal ileum intramural lesions are
shown in figure 5A-C. The predicted probability to have
score 0, i.e. no recurrence, when ICA wall thickness is ≤
3.5 mm, is > 80% in absence of intramural lesions of neo-
terminal ileum (wall thickness ≤ 3 mm, i.e. extension 0)
and it progressively decreases to 23% as intramural
lesions of the neo-terminal ileum increases up to 20 cm.
Conversely, the predicted probability to have score ≥ 2 is
< 1% in absence of intramural lesions of neo-terminal
ileum when ICA wall thickness is ≤ 3.5 mm and progres-
sively increases to > 80% for ICA wall thickness ≥10 mm.
The probability to have score ≥ 2 progressively increases
from 27% to 80% as intramural lesions extension of the
neo-terminal ileum increases from 3 cm to 20 cm when
ICA wall thickness is ≥8 mm.
All analyses were performed also using only the first
assessment, ultrasonography and endoscopy, for the 58
patients and the results were consistent with those pre-
sented (data not shown).
Discussion
In patients with Crohn's disease (CD) submitted to ileal
resection the evolution of post-operative recurrent CD
lesions can be prospectively assessed since their onset.
Patients with diffuse recurrent lesions in the neo-termi-
nal ileum within 1 year of resection present symptoms
earlier and are more prone to have complications than
patients with no or very mild lesions. However, even min-
imal recurrent CD lesions such as aphtae have the ten-
dency to progress into more severe involvement such as
ulcerations and strictures [13]. Based on these observa-
tions it has been proposed that patients with CD have
endoscopic evaluation of the neo-terminal ileum 6 to 12
months after surgery to guide therapeutic management
[14]. Because of its invasiveness and need of intestinal
preparation patients' compliance to undergo colonoscopy
is poor [3]. Furthermore the endoscopy cannot explore
the neo-terminal ileum in patients with score 4 and stric-
ture of ileo-colonic anastomosis or of neo-terminal
ileum. Finally ileo-colonoscopy cannot exclude other pos-
sible localizations in more proximal parts of small bowel
Figure 3 Scatter plot of pairs of US values of the extension of in-
tramural lesions at the level of the neo-terminal ileum and the 
wall thickness at level of the ileo-colonic anastomosis in 111 eval-
uations (58 patients) and estimated correlation.Pallotta et al. BMC Gastroenterology 2010, 10:69
http://www.biomedcentral.com/1471-230X/10/69
Page 7 of 11
requiring additional ad hoc investigations, the most
widely used of which is small bowel standard radiology.
However, because of radiation exposure radiology cannot
be used at will and should be minimized [15] particularly
in young people, child bearing age women, and in those
who may require repetitive assessments for the follow-up
of CD as in patients submitted to surgery.
A non-invasive method which visualizes the entire
small bowel such as MRI [16-18] or US performed after
the ingestion of oral contrast [4-7] is likely to improve
Table 2: Demographic, clinical and SICUS characteristics of patients by Rutgeerts score at each pair evaluation (N = 111)
Score 0 Score 1 Score ≥2 p value
Female, N (%) 11 (38%) 12 (39%) 15 (29%) 0.47
Male, N (%) 18 (62%) 19 (61%) 36 (71%)
Median age, (IQR) yrs 34.7 (28.7-45) 43.4 (34.8-51) 53.9 (34.7-62) 0.01
Median CD duration before surgery (IQR) months 48 (7-63) 22 (1-68) 12 (3-120) 0.45
Median interval from surgery and evaluation (IQR) months 33.3 (11-59) 36 (20-66) 59.6 (25-114) 0.05
Median CDAI (IQR) 66 (29-93) 39 (17-94) 44 (23-144) 0.19
CDAI ≥ 150, N (%) 2 (7%) 2 (6%) 11 (22%) 0.04
CDAI < 150 N (%) 27 (93%) 29 (94%) 40 (78%)
Presence of symptoms N (%) 9 (31%) 12 (39%) 29 (57%) 0.11
Median ICA wall thickness (IQR) mm 3 (2.5-3.8) 7 (6-9) 10 (9-12) < 0.001
Median neo-terminal ileal extension of increased wall thickness, 
(IQR) cm
0 1 (1-6.5) 13 (7-20) < 0.001
IQR: Interquartile range
Table 3: Estimated adjusted odds ratios (AOR) with 95% confidence intervals (95% CI) from two logistic models of having 
Rutgeerts score 0 vs 1-4 (section A), and 0 vs 1 (section B) on the basis of ICA wall thickness value and extension of 
increased (> 3 mm) neo-terminal ileal wall thickness
AOR 95% CI p value
Score 0 vs. 1-4 (section A)
ICA wall thickness (for 1 mm increase) 1.96 1.22-3.15 0.01
Extension of increased (> 3 mm) neo-terminal ileal wall thickness (for 1 cm increase) 1.18 1.08-1.30 < 0.01
Score 0 vs. 1 (section B)
ICA wall thickness (for 1 mm increase) 1.81 1.12-2.93 0.02
Extension of increased (> 3 mm) neo-terminal ileal wall thickness (for 1 cm increase) 1.15 1.06-1.24 < 0.01Pallotta et al. BMC Gastroenterology 2010, 10:69
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patient's compliance to undergo follow-up controls that
can be planned early after surgery and timely adjusted at
will. A limitation of MRI is the inability to prolong the
observation so to observe properly distended and not
contracting small bowel loops even when performed with
enteroclysis [16,17]. A limitation of oral contrast US
could be the patient's refusal to ingest large amount of
solution [8]. Following a previous SICUS study in which
variable volumes (125 ml-1,000 ml) of macrogol solution
were tested, the amount of 375 ml was identified as the
one properly distending the entire small bowel [19] and
acceptable by virtually all patients [6,7] as demonstrated
in the present study.
Normal intestinal wall thickness of ≤3 mm has been
identified at SICUS with repeated measurements at dif-
ferent levels of the small bowel in healthy subjects [5,20].
Based on this cut-off normal value of ≤3 mm it has been
shown that the diagnostic accuracy of SICUS is compara-
ble to that of small bowel follow-through [6,7] in detect-
ing suspected small bowel pathology and of
intraoperative findings in assessing site and extension of
CD lesions [7].
Up to now the normal value of wall thickness of ICA in
patients submitted to intestinal resection for CD compli-
cations is not known. In the present study the US value of
3.5 mm or more of wall thickness at the level of the ileo-
colonic anastomosis predicted the presence of Crohn's
disease recurrence in 100% of the patients. Increasing val-
ues of ICA wall thickness are significantly associated with
increasing Rutgeerts severity score (figure 2A). Based on
these findings the wall thickness of 3.5 mm appears to be
the cut-off value to differentiate normal from abnormal
ileo-colonic anastomosis in CD patients. To confirm this
observation further studies should be performed in a
larger CD population and comparatively in patients
undergoing ileo-colonic anastomosis for non inflamma-
tory disease.
Previous studies have assessed wall thickness after
curative ileal resection in CD patients at the level of neo-
terminal ileum with MR and US [17,20]. Both MR and US
did not provide sufficient resolution to differentiate ini-
tial wall thickening in patients with endoscopic scores 1
and 2. Recently two ultrasound studies [8,9] reported that
wall thickness >4 mm at the level of neo-terminal ileum
had a high sensitivity in detecting severe endoscopic CD
recurrence (i.e score 3 and score 4) as opposed to a low
sensitivity in detecting mild lesions (score 1 and score 2).
Differently from these studies limited to the US assess-
ment of wall thickness of the neo-terminal ileum with no
assessment of its extension, in the present one the wall
thickness of the ileo-colonic anastomosis, expressed as
the sum of the colonic and ileal limbs, and of the exten-
sion of intramural lesions of neo-terminal ileum were
used in a model in order to differentiate patients with no
recurrent CD lesions from those with recurrence and,
more importantly, from those with low grade CD recur-
rence (i.e. score 1). The ROC curve analysis shows that
the two combined variables represent an almost perfect
tool in discriminating patients with score 0 from those
with score 1-4 and a good tool in discriminating patients
with score 0 from those with score 1. Therefore a relevant
finding of the present study is that both variables, i.e., the
increased wall thickness at level of the ileo-colonic anas-
tomosis and the intramural extension of the lesion at the
level of the neo-terminal ileum, should be taken into
account to differentiate patients with endoscopic score 0
from score 1 and score 1 from score 2 and the latter from
the more severe scores. At the first observation per-
formed 6 months after surgery ICA wall thickening and
normal wall thickness of the neo-terminal ileum was
detected in 31% of the patients, indicating that a minimal
involvement of the ICA precedes extension of the CD
recurrent inflammation in the neo-terminal ileum. It is
thus of note that assessment of ICA wall thickness at
SICUS is relevant to detect postoperative recurrent lesion
earlier than the usual US assessment of wall thickness
limited to the neo-terminal ileum.
Differently from endoscopic scoring system, this study
finds an association between the US grading of intramu-
ral lesion at the level of ICA and its extension along the
Figure 4 ROC curve analysis. Accuracy of the combined US values, 
i.e. intramural lesions extension at the level of the neo-terminal ileum 
and wall thickness values at the level of the ileo-colonic anastomosis, 
in discriminating patients with Rutgeerts score 0 vs 1-4 (section A) and 
0 vs 1 (section B).Pallotta et al. BMC Gastroenterology 2010, 10:69
http://www.biomedcentral.com/1471-230X/10/69
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neo-terminal ileum. The observation that in patients with
Rutgeerts score 1 the lesions were confined to ICA in 17/
31 (54%) at SICUS and in 29/31 (93%) at endoscopy sug-
gests that a substantial intramural involvement may
occur in the presence of few aphtae not accompanied by
gross mucosal alterations. In addition, results of the pres-
ent study indicate that while mucosal lesions were associ-
ated with intramural lesions in all patients with Rutgeerts
score 1-4, in 4 patients intramural lesions, confirmed at
MRI and histology, were not associated with mucosal
lesions. This finding may indicate that CD inflammation
does not necessarily imply the damage of the epithelial
lining as also supported by the observation that in 3
patients with an early intramural recurrence at 6 months,
mucosal lesions became apparent at ileo-colonoscopy 1
year later. Indeed it has been shown [21] that in the pres-
Figure 5 Predicted probabilities of having a score of 0 (section A), 1 (section B), and ≥2 (section C) from a polychotomous ordinal logistic 
model with ICA wall thickness and extension of neo-terminal intramural lesions as covariates. Section A. In absence of intramural lesion (ex-
tension 0) of neo-terminal ileum, the predicted probability to have score 0 is > 80% (a) when ICA wall thickness is ≤ 3.5 mm and progressively decreas-
es to < 15% for ICA wall thickness ≥ 8 mm (b). The probability to have score 0 progressively decreases from 75% (c) to 23% (d) for intramural lesions 
of the neo-terminal ileum increasing from 3 cm to 20 cm. Section B. In absence of intramural lesion (extension 0) of neo-terminal ileum, the predicted 
probability to have score 1, progressively increases from 23% (a) to 66% (b) for wall thickness of ICA increasing from 3.5 mm to 8 mm. In absence of 
intramural lesion (extension 0) of neo-terminal ileum, the probability to have score 1 with ICA wall thickness > 9 mm is low (< 50%) (c). When the 
extension of intramural lesions at the level of neo-terminal ileum increases from 3 to 20 cm, the probability to have score 1 progressively increases 
from 24% (d) to 66% (e). Section C. In absence of intramural lesion (extension 0) of neo-terminal ileum, the predicted probability to have score ≥2 is 
< 1% (a) when ICA wall thickness is ≤ 3.5 mm and progressively increases to >80% (b) for ICA wall thickness >10 mm. With ICA wall thickness ≥8 mm 
and with intramural lesions of the neo-terminal ileum increasing from 3 cm to 20 cm, the probability to have score ≥2 progressively increases from 
27% (c) to 80% (d).Pallotta et al. BMC Gastroenterology 2010, 10:69
http://www.biomedcentral.com/1471-230X/10/69
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ence of inflammation, and occasionally even of granulo-
mas at histology of the mucosal biopsy, endoscopic
appearance can be completely normal. Thus recurrence
can be detected as an intramural lesion without any
accompanying mucosal alterations.
Similar to previous report [1], the degree of endoscopic
severity of mucosal lesion in this study was not associated
with the extension of wall thickening which was
extremely variable, irrespective of the endoscopic score 1
(0-30 cm), 2 (0-40 cm), 3 (1-60 cm) and 4 (1-55 cm).
Notably, in this study the presence of stenoses did not
allow a proper assessment of CD recurrence at endoscopy
in 78% of patients with score 4. In such circumstances,
knowledge of the length of the stenosis, that can be
assessed at SICUS and not at endoscopy, appears relevant
for the possible indication to perform in these patients a
perendoscopic dilatation. In the study by Rutgeerts et al
patients with no (score 0) or very mild (score 1) and those
with severe (score 3, and score 4) lesions at endoscopy
were grouped together as they had, respectively, nearly
asymptomatic or aggressive disease 1 year after surgery.
Patients with intermediate severity of lesions (score 2)
had no clear clinical prognosis as they progressed with
either mild or aggressive disease.
By assessing both wall thickening at the level of the
ileo-colonic anastomosis and its proximal extension in
the neo-terminal ileum, SICUS could be proposed to
grade the severity of intramural involvement of recurrent
CD lesions in patients submitted to ileal resection. The
proposed model predicts the absence of recurrence in
more than 80%, and the presence of very mild CD recur-
rence (i.e. score 1) in more than 65%, of patients indepen-
dently from any other variables.
Based on our results neither the CD disease activity as
assessed with CDAI nor symptoms are associated with
endoscopic score nor with severity and extension of
intramural lesions, while the duration of CD before sur-
gery appears to be marginally associated. This result may
be explained by the low reliability of the CDAI system in
the assessment of disease activity in patients with previ-
ous extensive ileo-colonic resection [22]. Identification of
the minimal post-operative recurrence may be relevant in
view of the development of more effective treatment that
can be used to prevent the progressive development from
mild to severe lesions that affects more than 70% of
patients [13].
Since the US methods are operator-dependent the pres-
ent study should have also assessed the inter-and intra-
observer variability of SICUS findings. To limit intra-
observer variability three measurements of ICA wall
thickness and of the increased wall thickness extension in
the neo-terminal ileum were performed and their mean
calculated. Inter-observer variability should be evaluated
in future studies.
Conclusions
In conclusion the most relevant finding of the present
study is that after ileal resection a non-invasive US
method that evaluates the thickness of the ileo-colonic
anastomosis, not differently from endoscopy, can detect
initial, low grade CD recurrence, but, in addition and dif-
ferently from endoscopy, it can assess the extension of the
intramural lesion in all patients with CD recurrence even
if luminal stenoses are present. A model based on the US
assessment of the thickness of ileo-colonic anastomosis
and the extension of the intramural involvement of the
neo-terminal ileum may be proposed to grade the sever-
ity of the post-surgical recurrence in patients submitted
to ileal resection for Crohn's disease.
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